Inferra AI / Company / TSNDF
TerrAscend
TSNDF · Health Care
Last earnings Aug 6, 2026
Key results
Net revenuequarter
$67.1 Million
Net Revenue of $67.1 Million, Up Sequentially and
SEC original ↗TerrAscend — Earnings release (8-K exhibit)EX-99Aug 6, 2026
Net Revenue of $67.1 million, compared to $65.5 million in the first quarter of 2026 and $65.0 million in the second quarter of 2025 •
SEC original ↗TerrAscend — Earnings release (8-K exhibit)EX-99Aug 6, 2026
Free cash flowquarter
9.9%
Operating Cash Flow Yield of 12.5% and Free Cash Flow Yield of 9.9% is calculated by taking Net Cash Provided from Continuing Operations and Free Cash Flow on a trailing twelve-month basis and dividing by the market value of the Company’s outstanding and exchangeable shares as of June 30, 2026.
SEC original ↗TerrAscend — Earnings release (8-K exhibit)EX-99Aug 6, 2026
Source: BDSA Second Quarter 2026 Financial Results Net revenue for the second quarter of 2026 was $67.1 million, compared to $65.5 million for the first quarter of 2026, and $65.0 million for the second quarter of 2025.
SEC original ↗TerrAscend — Earnings release (8-K exhibit)EX-99Aug 6, 2026
Revenuequarter
$22.9 million
G&A expenses for the second quarter of 2026 were $22.9 million and 34.0% of revenue, compared to $21.5 million and 32.8% of revenue for the first quarter of 2026, and $21.0 million and 32.3% of revenue for the second quarter of 2025.
SEC original ↗TerrAscend — Earnings release (8-K exhibit)EX-99Aug 6, 2026
Free cash flow was $5.7 million in the second quarter of 2026, representing the twelfth consecutive quarter of positive free cash flow.
SEC original ↗TerrAscend — Earnings release (8-K exhibit)EX-99Aug 6, 2026
Gross marginquarter
$36,250 thousand
Gross profit 36,250 33,235 70,852 67,916
SEC original ↗TerrAscend — Earnings release (8-K exhibit)EX-99Aug 6, 2026
AI analysis
Q2 2026 · reported Aug 6, 2026
Based on: Earnings release + parent 8-K — transcript not held
Headline figures
| Metric | Q2 2026 | Prior qtr | Year ago |
|---|---|---|---|
| Net revenue | $67.1 Million | — | — |
| Free cash flow | 9.9% | — | — |
| Revenue | $22.9 million | — | — |
| Gross margin | $36,250 thousand | — | — |
Guidance · company-stated
No guidance located in the held release
Margin
Cash flow & capex
Capital allocation
During the six month period ending June 30, 2026, the Company completed the repurchase of 578,500 shares through its normal course issuer bid at a weighted average price of $0.67 USD per share.
Event summary
TerrAscend — Earnings release (2026-08-06)
Based on: Earnings release + parent 8-K — transcript not held
Guidance & outlook
No guidance located in the held release
Capital allocation
During the six month period ending June 30, 2026, the Company completed the repurchase of 578,500 shares through its normal course issuer bid at a weighted average price of $0.67 USD per share.
SEC original ↗TerrAscend — Earnings release (8-K exhibit)EX-99Aug 6, 2026
Wild added, “During the quarter, we strengthened our balance sheet through an oversubscribed convertible debenture financing that extended our convertible debt maturities to 2031 at a lower interest rate, and we signed an agreement to acquire our fifth dispensary in New Jersey.
SEC original ↗TerrAscend — Earnings release (8-K exhibit)EX-99Aug 6, 2026
• Paid down $10.0 million on the principal of the Company’s term loan, which brings year-to-date term loan repayments to $15.5 million.
SEC original ↗TerrAscend — Earnings release (8-K exhibit)EX-99Aug 6, 2026
Capital expenditures were $1.6 million in the second quarter of 2026, primarily related to ongoing cultivation and facility optimization projects.
SEC original ↗TerrAscend — Earnings release (8-K exhibit)EX-99Aug 6, 2026
Strategy & priorities
These actions enhance our financial flexibility and reinforce our disciplined approach to capital allocation and strategic growth.
SEC original ↗TerrAscend — Earnings release (8-K exhibit)EX-99Aug 6, 2026
com 689-345-4114 Investor Relations Contact: KCSA Strategic Communications Valter Pinto, Managing Director TerrAscend@KCSA.
SEC original ↗TerrAscend — Earnings release (8-K exhibit)EX-99Aug 6, 2026
Risks & headwinds
The enforcement of federal laws in the United States is a significant risk to the business of the Company and any proceedings brought against the Company thereunder may adversely affect the Company’s operations and financial performance.
SEC original ↗TerrAscend — Earnings release (8-K exhibit)EX-99Aug 6, 2026
Forward-looking information and forward-looking statements are subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information and forward-looking statements.
SEC original ↗TerrAscend — Earnings release (8-K exhibit)EX-99Aug 6, 2026
Competitors
Competitors & peers
Same GICS sector — classification peers, not declared competitors
Filings
28 documents- Q2 2026
- 8-KTSNDF
Aug 25, 2026
- EX-99TSNDF
Aug 25, 2026
- 10-QTSNDF
Aug 6, 2026
- 8-KTSNDF
Aug 6, 2026
- Q1 2026
- 8-KTSNDF
Jun 29, 2026
- EX-99TSNDF
Jun 29, 2026
- 8-KTSNDF
Jun 25, 2026
- EX-99TSNDF
Jun 25, 2026
- 8-KTSNDF
Jun 15, 2026
- 10-QTSNDF
May 7, 2026
- 8-KTSNDF
May 7, 2026
- 8-KTSNDF
Apr 27, 2026
- 8-KTSNDF
Apr 16, 2026
- Q4 2025
- 10-KTSNDF
Mar 12, 2026
- 8-KTSNDF
Mar 12, 2026
- Q3 2025
- 8-KTSNDF
Dec 30, 2025
- 10-QTSNDF
Nov 6, 2025
- 8-KTSNDF
Nov 6, 2025
- Q2 2025
- 10-QTSNDF
Aug 7, 2025
- 8-KTSNDF
Aug 7, 2025
- 8-KTSNDF
Jul 9, 2025
- Q1 2025
- 8-KTSNDF
Jun 30, 2025
- 8-KTSNDF
Jun 24, 2025
- 8-KTSNDF
Jun 2, 2025
- 10-QTSNDF
May 8, 2025
- 8-KTSNDF
May 8, 2025
- Q4 2024
- 10-KTSNDF
Mar 6, 2025
- 8-KTSNDF
Mar 6, 2025
Earnings releases
4 documents- Q2 2026
- EX-99TSNDF
Aug 6, 2026
- Q1 2026
- EX-99TSNDF
Jun 29, 2026
- EX-99TSNDF
Jun 29, 2026
- EX-99TSNDF
May 7, 2026
Presentations
0 documentsNo presentations for TerrAscend are held in this edition of the library.
Transcripts
0 documentsNo transcripts for TerrAscend are held in this edition of the library.
See also the earnings calendar for every tracked company’s next earnings date.